How to buy Medpace stock (MEDP)

Medpace is a diagnostics & research business based in the US. Medpace shares (MEDP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $335.15 – a decrease of 3.12% over the previous week. Medpace employs 5,900 staff and has a trailing 12-month revenue of around $2.1 billion.

Our top picks for where to buy Medpace stock

Buy Medpace stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Medpace stock price (NASDAQ: MEDP)

Use our graph to track the performance of MEDP stocks over time.

Medpace shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$335.15
52-week range	$277.72 - $459.77
50-day moving average more info button	$339.73
200-day moving average more info button	$375.98
Wall St. target price	$347.92
PE ratio more info button	28.9589
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$11.43

Is it a good time to buy Medpace stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Medpace price performance over time

Historical closes compared with the close of $331 from 2024-12-18

1 week (2024-12-13)	-4.32%
1 month (2024-11-21)	-3.17%
3 months (2024-09-20)	-9.49%
6 months (2024-06-20)	-17.38%

1 year (2023-12-20)	9.19%
2 years (2022-12-20)	62.47%
3 years (2021-12-20)	54.86%
5 years (2019-12-20)	292.09%

Is Medpace stock undervalued or overvalued?

Valuing Medpace stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medpace's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medpace's P/E ratio

Medpace's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Medpace shares trade at around 29x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Medpace's PEG ratio

Medpace's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5764. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medpace's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Medpace's EBITDA

Medpace's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $437.5 million.

The EBITDA is a measure of a Medpace's overall financial performance and is widely used to measure a its profitability.

Medpace financials

Revenue TTM	$2.1 billion
Operating margin TTM	21.05%
Gross profit TTM	$925.1 million
Return on assets TTM	14.31%
Return on equity TTM	54.08%
Profit margin	17.66%
Book value	$28.42
Market Capitalization more info button	$10.3 billion

TTM: trailing 12 months

Medpace share dividends

We're not expecting Medpace to pay a dividend over the next 12 months.

Medpace share price volatility

Over the last 12 months, Medpace's shares have ranged in value from as little as $277.72 up to $459.77. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medpace's is 1.367. This would suggest that Medpace's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Medpace overview

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Frequently asked questions

What percentage of Medpace is owned by insiders or institutions?
Currently 17.828% of Medpace shares are held by insiders and 86.102% by institutions. How many people work for Medpace?
Latest data suggests 5,900 work at Medpace. When does the fiscal year end for Medpace?
Medpace's fiscal year ends in December. Where is Medpace based?
Medpace's address is: 5375 Medpace Way, Cincinnati, OH, United States, 45227 What is Medpace's ISIN number?
Medpace's international securities identification number is: US58506Q1094 What is Medpace's CUSIP number?
Medpace's Committee on Uniform Securities Identification Procedures number is: 58506Q109